To substantiate these findings, the colony-forming potential of AML (n = 5), HR-MDS (n = 5) and healthy (n = 5) BMMC-derived CD34+ cells after treatment with AFM28 and allogeneic NK cells was assessed. The gene discussed is CD34; the disease is myelodysplastic syndrome.